The growth in sexually transmitted infections (STIs), particularly gonorrhea, in Kenya surprises a lot of people.
Gonorrhea is a typical STI that can affect the genitalia, rectum, and throat in people who engage in sexual activity.
Although it is treatable and curable, it is very adept at evading the antibiotics that are used to treat it.
Dr. Teodora Wi, WHO Medical Officer with expertise in STIs, will speak on AMR, gonorrhea, and the potential spread of drug-resistant STIs.
He offered information that everyone should be aware of.
Key details:
- The number of treatment options for gonorrhoea have decreased as a result of the significant rise in antimicrobial resistance in recent years.
- In 2020, there were 82 million new cases of gonorrhea.
In 2020, the WHO Western Pacific Region and African Region saw the majority of gonorrhea cases. - Ages 15 to 49 make up the majority of those affected.
- In 2020, there were 82 million new cases of gonorrhea.
- Ages 15 to 49 make up the majority of those affected.
The term “gonorrhoea superbugs” or “super gonorrhoea” refers to gonorrhoea that is highly resistant to ceftriaxone and azithromycin, the current recommended treatments for the disease, as well as penicillin, sulphonamides, tetracycline, fluoroquinolones, and macrolides.
Additionally
Men who have contracted gonorrhea may exhibit the following symptoms:
urinating in pain.
discharge coming out of the manhood’s tip.
Women who have gonorrhea may have the following signs and symptoms:
increased discharge from the cervix
urinating in pain.
bleeding after vaginal intercourse or in between periods.
